Compensates for lack of exocrine pancreatic function, has a proteolytic, amylolytic and lipolytic action. Included in the sustanon 250 gains enzymes (lipase, alpha-amylase, trypsin, chymotrypsin) contribute to the breakdown of proteins into amino acids, fats to glycerol and fatty acids, starch into dextrins and sugars.
It improves the functional condition of the gastrointestinal tract, normalizes the processes of digestion.
Trypsin inhibited the stimulated pancreatic secretion, providing an analgesic effect.
pancreatic enzymes are released from the dosage form in the alkaline environment of the small intestine because the protected from the action of gastric juice coating. Maximum enzyme activity observed after 30-45 minutes after oral administration.
Substitution treatment for exocrine pancreatic insufficiency: chronic pancreatitis, pancreatectomy, post-irradiation, indigestion, Remhelda syndrome (gastrocardiac syndrome), cystic fibrosis, flatulence, diarrhea non-infectious origin.
Food assimilation Violation (state after resection of the stomach and small intestine); to improve food digestion in patients with normal function of the gastrointestinal tract in the case of errors in the diet (eating fatty foods, large amounts of food, irregular meals), and in violation of chewing function, sedentary lifestyle, prolonged immobilization.
Preparing to X-ray examination and ultrasound of the abdominal cavity.
: Hypersensitivity to the drug, acute pancreatitis, exacerbation of chronic pancreatitis.
Dosing and Administration
The drug is taken by mouth without chewing, during or immediately after a meal. Adults : 2-4 tablets (50-100 IU) 3-4 times a day. Children – prescribed by a doctor.Single doses for children: 6-7 years – 25 units, 8-9 years – 25-50 IU, 1014 IU 50 years.
Allergic reactions. In some cases – diarrhea, constipation, feeling of discomfort in the stomach, nausea (causal relationship of these reactions to the action of sustanon 250 gains has not been established, since these phenomena are symptoms of exocrine pancreatic insufficiency). With prolonged use at high doses may develop hyperuricosuria, increased levels of uric acid in blood plasma. In the application of sustanon 250 gains in high doses may occur in children perianal irritation and irritation of the oral mucosa. Patients with cystic fibrosis may develop strictures in the ileocecal department and ascending colon.
Overdose Symptoms : hyperuricosuria, hyperuricemia. The children – constipation. Treatment : removal of the drug, symptomatic therapy.
Interaction with other drugs
With simultaneous application of sustanon 250 gains with iron preparations may decrease the absorption of the latter. The simultaneous use of antacids containing calcium carbonate, calcium and / or magnesium hydroxide, can reduce the effectiveness of sustanon 250 gains.
The safety of sustanon 250 gains during pregnancy has been poorly studied. Application is possible in cases where the expected benefit to the mother outweighs the potential risk to the fetus.
Product form :
10 tablets in contour bezgyachakova package of aluminum foil.
60 tablets in banks lighting glass with a triangular rim or jars with screw neck, bottles glass lighting glass.
On 60 tablets in plastic cans or plastic bottles.
6 contour bezgyachakova packages , jars, bottles, along with instructions for use are placed in a pile of cardboard.